Extracellular vesicle-aso constructs targeting stat6
AssigneeLonza Sales AG
InventorsDalia BURZYN, Sushrut KAMERKAR, Adam T. BOUTIN, Wendy BROOM, Sriram SATHYANARAYANAN, Ajay VERMA
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to extracellular vesicles, e.g., exosomes, comprising an antisense oligonucleotide (ASO), wherein the ASO comprises a contiguous nucleotide sequence of 10 to 30 nucleotides in length that is complementary to a nucleic acid sequence within a STAT6 transcript. Also provided herein are methods for producing the exosomes and methods for using the exosomes to treat and/or prevent diseases or disorders.
Claims32
An extracellular vesicle comprising an antisense oligonucleotide (ASO), which comprises a contiguous nucleotide sequence of 10 to 30 nucleotides in length, wherein the contiguous nucleotide sequence is the nucleotide sequence as set forth in SEQ ID NO:
- 185.
2-15. (canceled)
(canceled)
19-25. (canceled)
27-30. (canceled)
36-45. (canceled)
47-74. (canceled)
(canceled)
(canceled)
81-82. (canceled)
86-87. (canceled)
89-142. (canceled)
An extracellular vesicle comprising an antisense oligonucleotide (ASO) comprising the nucleotide sequence as set forth in SEQ ID NO:
- 185, wherein the ASO is 20 nucleotides in length and has the design of LLLDnLLL, wherein “n” is 14, “L” is an LNA, and “D” is a DNA;
- wherein all of the cytosine nucleobases in the ASO are 5′-methyl-cytosine nucleobases;
- wherein each of the internucleoside linkages in the ASO is a phosphorothioate linkage;
- wherein the ASO is linked to an anchoring moiety on the exterior surface of the extracellular vesicle;
- wherein the anchoring moiety comprises cholesterol;
- and
- wherein the ASO is linked to cholesterol by a linker comprising TEG and HEG.
Dependencies are inferred from the claim text.